BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38166774)

  • 1. The impact of Renin-Angiotensin System Inhibitors on bone fracture risk: a nationwide nested case-control study.
    Kim KM; Hwang EJ; Lee S; Yoon JH
    BMC Musculoskelet Disord; 2024 Jan; 25(1):3. PubMed ID: 38166774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do renin-angiotensin system inhibitors reduce risk for hepatocellular carcinoma?: A nationwide nested case-control study.
    Kim KM; Roh JH; Lee S; Yoon JH
    Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101510. PubMed ID: 33272886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between renin angiotensin aldosterone system blockers and future osteoporotic fractures in a hypertensive population - A population-based cohort study in Taiwan.
    Kao YT; Huang CY; Fang YA; Liu JC
    Int J Cardiol; 2020 Apr; 305():147-153. PubMed ID: 31955975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between renin-angiotensin-aldosterone system blockade and clinical outcomes in patients with hypertension: real-world observation from a nationwide hypertension cohort.
    Park CS; Kim B; Rhee TM; Lee HJ; Lee HS; Park JB; Kim YJ; Han KD; Kim HK
    Clin Res Cardiol; 2023 Nov; 112(11):1577-1586. PubMed ID: 36867200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ARB users exhibit a lower fracture incidence than ACE inhibitor users among older hypertensive men.
    Kwok T; Leung J; Barrett-Connor E;
    Age Ageing; 2017 Jan; 46(1):57-64. PubMed ID: 28181652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin-angiotensin system inhibitors and risk of fractures: a prospective cohort study and meta-analysis of published observational cohort studies.
    Kunutsor SK; Blom AW; Whitehouse MR; Kehoe PG; Laukkanen JA
    Eur J Epidemiol; 2017 Nov; 32(11):947-959. PubMed ID: 28752198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-varying risk associations of renin angiotensin system inhibitors with pneumonia and related deaths in a cohort of 252,616 patients with diabetes (2002-2019).
    Yang A; Shi M; Wu H; Lau ES; Fan B; Kong AP; Ma RC; Luk AO; Chan JC; Chow E
    Diabetes Res Clin Pract; 2022 Mar; 185():109233. PubMed ID: 35131377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of renin-angiotensin system inhibitor type and dosage on survival after transcatheter aortic valve implantation.
    Fischer-Rasokat U; Bänsch C; Renker M; Rolf A; Charitos EI; Weferling M; Liebetrau C; Herrmann E; Choi YH; Hamm CW; Kim WK
    Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 8(8):815-824. PubMed ID: 35441662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renin-angiotensin aldosterone system and osteoporosis: findings from the Women's Health Initiative.
    Carbone LD; Vasan S; Prentice RL; Harshfield G; Haring B; Cauley JA; Johnson KC
    Osteoporos Int; 2019 Oct; 30(10):2039-2056. PubMed ID: 31209511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Osteoporotic Fractures With Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors in Hypertensive Community-Dwelling Elderly.
    Butt DA; Mamdani M; Gomes T; Lix L; Lu H; Tu K;
    J Bone Miner Res; 2014 Nov; 29(11):2483-8. PubMed ID: 24806397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detrimental effect of renin-angiotensin blockade on progression of chronic kidney disease at later stages: A matter of dosage adjustment?
    Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F
    Nefrologia (Engl Ed); 2020; 40(1):38-45. PubMed ID: 31196659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of renin angiotensin system inhibitors on homocysteine levels and platelets reactivity in patients on dual antiplatelet therapy.
    Nardin M; Verdoia M; Gioscia R; Negro F; De Luca G
    Nutr Metab Cardiovasc Dis; 2021 Apr; 31(4):1276-1285. PubMed ID: 33549433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-Angiotensin System Inhibitors in Patients With COVID-19: A Meta-Analysis of Randomized Controlled Trials Led by the International Society of Hypertension.
    Gnanenthiran SR; Borghi C; Burger D; Caramelli B; Charchar F; Chirinos JA; Cohen JB; Cremer A; Di Tanna GL; Duvignaud A; Freilich D; Gommans DHF; Gracia-Ramos AE; Murray TA; Pelorosso F; Poulter NR; Puskarich MA; Rizas KD; Rothlin R; Schlaich MP; Schreinlecher M; Steckelings UM; Sharma A; Stergiou GS; Tignanelli CJ; Tomaszewski M; Unger T; van Kimmenade RRJ; Wainford RD; Williams B; Rodgers A; Schutte AE;
    J Am Heart Assoc; 2022 Sep; 11(17):e026143. PubMed ID: 36000426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers.
    Holloway-Kew KL; Betson AG; Anderson KB; Sepetavc F; Gaston J; Kotowicz MA; Liao WH; Henneberg M; Pasco JA
    Calcif Tissue Int; 2022 Oct; 111(4):396-408. PubMed ID: 35833952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J; Lee S
    Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis.
    Bang CN; Greve AM; Køber L; Rossebø AB; Ray S; Boman K; Nienaber CA; Devereux RB; Wachtell K
    Int J Cardiol; 2014 Aug; 175(3):492-8. PubMed ID: 25012498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of RAS inhibitors on all-site cancers and mortality in the Hong Kong diabetes surveillance database (2002-2019).
    Yang A; Wu H; Lau ESH; Shi M; Fan B; Kong AP; Ma RC; Luk AO; Chan JC; Chow E
    EBioMedicine; 2022 Sep; 83():104219. PubMed ID: 35970023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of renin-angiotensin system inhibitors on the survival of patients with rectal cancer.
    Zeman M; Skałba W; Wilk AM; Cortez AJ; Maciejewski A; Czarniecka A
    BMC Cancer; 2022 Jul; 22(1):815. PubMed ID: 35879682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between early worsening of kidney function and poor outcomes in patients treated with renin angiotensin system inhibitors: A meta-analysis.
    Yuan S; Liu Y; He W; Jin J; Liu L; He Q
    Nephrology (Carlton); 2021 Oct; 26(10):772-781. PubMed ID: 34165226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-angiotensin system modulation and outcomes in patients hospitalized for interstitial SARS-CoV2 pneumonia: a cohort study.
    Landolfo M; Maino A; Di Salvo E; Fiorini G; Peterlana D; Borghi C
    Intern Emerg Med; 2022 Aug; 17(5):1335-1341. PubMed ID: 35064437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.